Navigation Links
Early Detection Of Prostate Cancer For Complete Recovery From Prostate Cancer

Prostate cancer is the most common cancer affecting men and occurs in men 65 years or older. It is advised that Men above the age of 50 years should undergo the routine examination of prostate and also test for presence of // Prostate Specific Antigen, by monitoring the levels of PSA in blood. African-American men or men with a family history of the disease should begin regular prostate screening exams at an earlier age. Signs and symptoms of prostate cancer include changes in urinary flow (such as increased frequency, urgency or hesitancy), frequent night time urination, painful urination and blood in the urine.

Many treatment options are available for treatment of prostate cancer, prostate cancer can be easily cured if detected early and therapy is started. The treatment options depend up on the cancer stage and spread of the cancer. Hormone therapy, Prostate Surgery, external beam radiation therapy, radiation seed implants and proton beam therapy. September month is the world Prostate Cancer Awareness Month and various organizations are spreading information about early detection of prostate cancer in men.

“If caught early, prostate cancer is very treatable and often curable,” said Louis Harrison, M.D., Chair of the ASTRO Communications Committee and a radiation oncologist at Beth Israel Medical Center in New York. “Men over the age of 50 should have a regular screening; and if diagnosed with prostate cancer, it’s important that patients understand all of their treatment options by talking with several specialists, including a radiation oncology and an urologist.”

(Source: News wie)
'"/>




Page: 1

Related medicine news :

1. Early detection of prostate cancer
2. Early detection of heart attack
3. Early puberty linked to nutrition
4. Early Clue to Down Syndrome
5. Early delivery can prevent cancer
6. Early puberty more resistance
7. Early menopause- The cause
8. Early menopause- The cause
9. Early Warning System For Breast Cancer
10. Early therapy aids eyesight
11. Early detection of colorectal cancer may be hindered by coloured toilet disinfectants
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: